First, a previous study discovered that PD-L1 expression was highly consistent across histological specimens and matched pleural fluid from NSCLC patients, implying that if the primary tumor is responsive to anti-PD-L1 treatment, MPE may also respond [25]. The gene discussed is CD274; the disease is non-small cell lung carcinoma.